Stay updated on Expanded Access to Upadacitinib Clinical Trial

Sign up to get notified when there's something new on the Expanded Access to Upadacitinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Expanded Access to Upadacitinib Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The new screenshot shows minor visual/layout adjustments to the study page, while core study details (conditions, eligibility criteria, and contact information) remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T12:32:51.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    The page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.
    Difference
    8%
    Check dated 2025-10-05T17:19:37.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Update: version bumped to v3.1.0 with a new contact phone number 844-663-3742; previous version v3.0.2 removed.
    Difference
    0.2%
    Check dated 2025-09-28T10:11:15.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Expanded disease coverage and metadata (new diseases, categories, and identifiers) with updated timestamps; some old age-range and prior update-label details were removed.
    Difference
    9%
    Check dated 2025-09-21T06:43:50.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2, indicating a page update. The 'Back to Top' link was removed, a minor UI change.
    Difference
    0.5%
    Check dated 2025-09-14T00:22:00.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.5%
    Check dated 2025-09-06T21:16:56.000Z thumbnail image

Stay in the know with updates to Expanded Access to Upadacitinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Expanded Access to Upadacitinib Clinical Trial page.